| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5603698 | IJC Metabolic & Endocrine | 2017 | 6 Pages |
Abstract
We suggest that the effectiveness of β-blocker treatment for PVCs in CKD patients was observed in all 25(OH)D levels. However, the responsiveness was higher in patients with a normal range of 25(OH)D in comparison to patients with deficiency or insufficiency in 25(OH)D levels. Whether vitamin D supplementation increases the efficacy of beta-blocker mediated suppression of PVCs requires further evaluation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Márcio Galindo Kiuchi, Gustavo Ramalho e Silva, Luis Marcelo Rodrigues Paz, Shaojie Chen, Neil Alexander Hoye, Gladyston Luiz Lima Souto,